Sunshine Biopharma (SBFM) Non Operating Investment Income (2014 - 2015)
Sunshine Biopharma's (SBFM) quarterly Non Operating Investment Income came in at -$513155.0 in Q2 2015, up 32.97% on a YoY basis from -$385929.9 in Q2 2014, and up 32.97% quarter-over-quarter from -$765513.0 in Q2 2014.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Non Operating Investment Income (2014 - 2015) Analysis & Trends
Sunshine Biopharma (SBFM) has reported Non Operating Investment Income for 2 consecutive years, with -$513155.0 the latest figure, recorded in Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | - |
| 10 | Sunshine Biopharma | 1.56 Mn | -12.19 Mn | 2.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | -513,155.00 |
| Jun 30, 2014 | -765,513.00 |